Dear all,
After a successful Batch 2 of Healthcare Xplorers, we are back at it again
with 3 exciting new data challenges
<https://healthcare-xplorers.com/challenges/>. Check it out!
_______
Are you a student or PhD and want to boost your career? Do you love data
and to think out-of-the-box? Then take your chance and bring your idea to
life with Roche. Participating is really easy: have a look at our
challenges, select the one you want to tackle and submit your idea (3 to 5
PPT slides). Read more on how it works
<https://healthcare-xplorers.com/how-it-works/>.
Please note: You will have time to submit your idea until mid July 2021.
Challenge 1: Augmented patient pathways in oncology
<https://healthcare-xplorers.com/challenges/augmented-patient-pathways-in-oncology/>
Challenge 2: Develop machine learning-based methods for early anomaly
detection in diagnostics instrument and assay data
<https://healthcare-xplorers.com/challenges/develop-machine-learning-based-methods-for-early-anomaly-detection-in-diagnostics-instrument-and-assay-data/>
Challenge 3: Generating synthetic patient-reported outcomes to foster
collaboration in clinical settings
<https://healthcare-xplorers.com/challenges/generating-synthetic-patient-reported-outcomes-to-foster-collaboration-in-clinical-settings/>
Greenfield Challenge: Do you have another great idea which you would like
to put into practice with Roche as a partner? Propose a data-driven
healthcare project to us here
<https://healthcare-xplorers.com/challenges/greenfield-challenge/>
Any questions? Please feel free to contact us: healthcare.xplorers(a)roche.com
Your Healthcare Xplorers team
--
*HealthcareXplorers-Team*
*Academic Minds for Innovation*
Roche Diagnostics GmbH
Sandhofer Strasse 116
68305 Mannheim / Germany
mailto:healthcarexplorers@roche.com
<healthcarexplorers(a)roche.com>
Roche Diagnostics GmbH
Sandhofer Straße 116; D‑68305 Mannheim; Telefon +49‑621‑759‑0; Telefax
+49‑621‑759‑2890
Sitz der Gesellschaft: Mannheim - Registergericht: AG Mannheim HRB 3962 -
Geschäftsführung: Claus Haberda; Andreas Schmitz -
Aufsichtsratsvorsitzender: Dr. Thomas Schinecker
Confidentiality Note
This message is intended only for the use of the named recipient(s) and may
contain confidential and/or privileged information. If you are not the
intended recipient, please contact the sender and delete the message. Any
unauthorized use of the information contained in this message is prohibited.
Zeige Antworten nach Datum